biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Protalix

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jun 09, 2023 1:27pm

78 Views

Post# 35488823

RE:RE:RE:RE:RE:RE:Protalix

Lol. You're such a wag, DaTruth1234.

You're trying too hard to insult me, DT. Your material is nothing more than what I posted myself. And here you are, trying to make fun of my intelligence!

Well, I figure that whatever's wrong in my world can be fixed. You, well, you are what you are. There's no fixing that.

jd

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload